Thank you for your interest. Give here your contact details and you'll receive an email with the pdf file you request.
Sign up to our monthly newsletter to receive our news.
Viruses hijack cancer genes to cause leukemia
A team of researchers led by Anne Van den Broeke (GIGA-ULg and Institut Jules Bordet-ULB) has uncovered a novel mechanism by which viruses cause leukemia. These new findings, published in Nature Communications, could be key to the understanding of virus induced cancers and the development of targeted therapeutic strategies for a very aggressive type of leukemia.
Approximately 12% of human cancers worldwide are attributed to viral infection. Human T-cell leukaemia Virus-1 (HTLV-1), the first oncogenic retrovirus discovered in human, infects an estimated 20 million people worldwide and causes adult T cell leukemia (ATL), an aggressive leukemia with an extremely poor prognosis. The closely related Bovine Leukemia Virus (BLV) produces a very similar disease in cattle and sheep, with the latter providing a unique outbred animal model for cancer research.
It has been generally assumed that leukemia development is dependent on the production of cancer-promoting agents by the virus yet is independent of the location of the virus within the genome of the cancer cell. The research team was the first to discover that, contrary to the prevailing dogma, HTLV-1 and BLV do not integrate randomly in the host genome but rather in the vicinity of genes involved in cancer (“cancer drivers”). The most surprising observation was that these cancer drivers were systematically positioned upstream relative to the virus rather than downstream as would be expected mechanistically. The team further demonstrated the perturbation of the corresponding genes via interactions with viral “antisense” transcripts (viral factors synthesized in the opposite orientation relative to the classical viral products), revealing a novel mechanism by which oncogenic viruses and antisense transcription contribute to cancer development.
Using novel next generation sequencing (NGS) methods, the researchers further showed that, in both humans and animals, these perturbations are present long before the leukemia becomes aggressive. The screen for finding the precise viral insertion spots in the sheep genome revealed a list of several hundreds of genes, a third of which have not been previously reported in cancer, thus providing a treasure trove of new candidate cancer driver genes for further investigations.
The study, carried out in collaboration with scientists of the Necker University hospital in Paris and the VIDO/Intervac research institute of the University of Saskatchewan in Canada, is the result of interdisciplinary research that combines oncology, viral pathogenesis and animal genomics.
New avenues for cancer research and clinical applications
Having demonstrated the sequestration of host cancer drivers by the virus and the unexpected role of viral antisense transcripts in this process, the team now hopes that further research will be able to identify specific inhibitors as a basis for the future development of targeted therapies. Finally, the NGS method developed in this study can be applied to monitor ATL patients, enabling better prediction of relapse and providing clinicians with a molecular tool to evaluate response to treatment.
Nicolas Rosewick, Keith Durkin, Ambroise Marçais, Maria Artesi, Vincent Hahaut, Philip Griebel, Natasa Arsic, Véronique Avettand-Fenoel, Arsène Burny, Carole Charlier, Olivier Hermine, Michel Georges & Anne Van den Broeke (2017)
Cis-perturbation of cancer drivers by the HTLV-1/BLV proviruses is an early determinant of leukemogenesis, Nature Communications, doi: 10.1038/NCOMMS15264
In collaboration with a team at the University of California at Los Angeles (UCLA), researchers from GIGA-Neurosciences have discovered a new gene responsible for a seizure syndrome called juvenile myoclonic epilepsy (JME). This discovery was made as part of an international consortium that studies genetic abnormalities responsible for epileptic diseases. It is being published this week in
The LIGHTSHEET MICROSCOPY can deliver optical sections, 3D reconstructions and timelapse movies of whole sample volumes at subcellular resolutions. The fast scan speeds and low phototoxicity of the lightsheet allow to record the development of fluorescent transgenic animals over long time periods, such as zebrafish embryos. Alternatively 3D reconstructions of fixed whole organs or whole embryos,
The researchers discovered that this cellular dialogue controls the growth of the cerebral cortex and that its impairment leads a cortical malformation previously associated with autism in mice . Their results are published in the prestigious scientific journal Cell. The cerebral cortex contains excitatory and inhibitory interneurons. The former are produced locally and move by